Remove 2025 Remove Pharmaceutical Manufacturing Remove Pharmacy Technician
article thumbnail

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Pharmacy Times

SHOW MORE Lab will help enable broader adoption of advanced manufacturing technologies and state-of-the-art quality solutions. Rockville, MD - June 4, 2025 - The U.S. USP’s unique capabilities and decades of expertise can help overcome the barriers that have limited the adoption of advanced manufacturing technologies.

article thumbnail

Conference Connect: Determining the Future of Specialty Pharmacy

Pharmaceutical Commerce

How Recent Executive Orders Impact the Drug Pricing Landscape Nicholas Saraceno, Editor May 30th 2025 Podcast Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

Pharmacy Times

At the American Society of Health-System Pharmacists (ASHP) Pharmacy Futures 2025 meeting, presenter Madison Wood, PharmD, CPh, BCPS, reviewed a groundbreaking model for integrating specialty pharmacists directly into neurology care teams. Unless issues arise, patients continue with follow-up visits every 6 months.

article thumbnail

Do We Really Pay More for Prescription Drugs in the United States?

Pharmacy Times

Author(s): Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief Yes. Author(s): Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief Yes. President Trump Signs Executive Order to Create Most Favored Nations On May 12, 2025, President Donald J. But that doesn’t tell the whole story. Add President Joseph R.

article thumbnail

Pharmacy Policy Updates for June 2025

Pharmacy Times

3,4 How this pricing model will be implemented and whether pharmaceutical manufacturers will be able to meet the expectations of the 2025 executive order, if upheld, is uncertain. The order states that if manufacturers are unable to meet the 30-day deadline, the secretary of the Department of Health and Human Services, Robert F.